# US 2002/0055113 A1 · 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0055113 A1
- Document ID: US20020055113A1
- Status: Published application
- Kind: A1
- Application number: 09/941,964
- Filed: 2001-08-28
- Published: 2002-05-09
- Earliest claimed: 1999-06-17
- Assignees: Gilead Sciences, Inc.
- Inventors: Daniel Drolet; Larry Gold
- Web page: https://patentgrep.com/patent/US20020055113A1

## CPC

- C12N 15/1137: {against enzymes (viral enzymes C12N15/1131; receptors C12N15/1138)}
- C12Q 1/6811: Selection methods for production or design of target specific oligonucleotides or binding molecules
- C12N 2310/18: acting by a non-sequence specific mechanism
- C12N 2310/322: 2'-R Modification
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods are described for the identification and preparation of nucleic acid ligands to calf intestinal phosphatase. Included in the invention are specific RNA ligands to calf intestinal phosphatase identified by the SELEX method.

## Claims

### Claim 1

A method of identifying nucleic acid ligands to calf intestinal phosphatase (CIP), the method comprising:
a) preparing a candidate mixture of nucleic acids;
b) contacting the candidate mixture of nucleic acids with CIP, wherein nucleic acids having an increased affinity to CIP relative to the candidate mixture may be partitioned from the remainder of the candidate mixture;
c) partitioning the increased affinity nucleic acids from the remainder of the candidate mixture; and
d) amplifying the increased affinity nucleic acids to yield a mixture of nucleic acids enriched for nucleic acids with relatively higher affinity and specificity for binding to CIP, whereby a nucleic acid ligand of CIP may be identified.

### Claim 2 (depends on 1)

The method of claim 1 further comprising:
e) repeating steps b), c), and d).

### Claim 3 (depends on 1)

The method of claim 1 wherein said candidate mixture of nucleic acids is comprised of single stranded nucleic acids.

### Claim 4 (depends on 3)

The method of claim 3 wherein said single stranded nucleic acids are ribonucleic acids.

### Claim 5 (depends on 3)

The method of claim 3 wherein said single stranded nucleic acids are deoxyribonucleic acids.

### Claim 6 (depends on 4)

The method of claim 4 wherein said nucleic acids are 2′-F (2′-fluoro) modified ribonucleic acids.
